• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

American Gastroenterological Association technical review on the management of Barrett's esophagus.

作者信息

Spechler Stuart J, Sharma Prateek, Souza Rhonda F, Inadomi John M, Shaheen Nicholas J

机构信息

VA North Texas Health Care System and University of Texas Southwestern Medical Center Dallas, Texas, USA.

出版信息

Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031.

DOI:10.1053/j.gastro.2011.01.031
PMID:21376939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3258495/
Abstract
摘要

相似文献

1
American Gastroenterological Association technical review on the management of Barrett's esophagus.美国胃肠病学会关于巴雷特食管管理的技术审查
Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031.
2
American Gastroenterological Association medical position statement on the management of Barrett's esophagus.美国胃肠病学会关于巴雷特食管管理的医学立场声明。
Gastroenterology. 2011 Mar;140(3):1084-91. doi: 10.1053/j.gastro.2011.01.030.
3
Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?巴雷特食管：在内镜治疗后的监测中，发育异常是一个可靠的标志物吗？
Curr Gastroenterol Rep. 2001 Oct;3(5):371-4. doi: 10.1007/s11894-001-0075-7.
4
Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.巴雷特食管：历史视角、核心实践的最新进展以及管理未来发展的预测。
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:11-30. doi: 10.1111/j.1440-1746.2010.06535.x.
5
Identification and clinical implementation of biomarkers for Barrett's esophagus.巴雷特食管生物标志物的识别与临床应用
Gastroenterology. 2012 Mar;142(3):435-441.e2. doi: 10.1053/j.gastro.2012.01.013. Epub 2012 Jan 20.
6
Strategies to improve outcomes in esophageal adenocarcinoma.改善食管腺癌结局的策略。
Expert Rev Anticancer Ther. 2014 Jun;14(6):677-87. doi: 10.1586/14737140.2014.895668. Epub 2014 Mar 13.
7
Past, present and future of Barrett's oesophagus.巴雷特食管的过去、现在与未来
Eur J Surg Oncol. 2017 Jul;43(7):1148-1160. doi: 10.1016/j.ejso.2017.02.004. Epub 2017 Feb 16.
8
Evaluation and Management of Premalignant Conditions of the Esophagus: A Systematic Survey of International Guidelines.食管癌前病变的评估和管理：国际指南的系统调查。
J Clin Gastroenterol. 2019 Oct;53(9):627-634. doi: 10.1097/MCG.0000000000001247.
9
[Barrett's esophagus: diagnosis and therapy].[巴雷特食管：诊断与治疗]
Praxis (Bern 1994). 2005 May 25;94(21):861-8. doi: 10.1024/0369-8394.94.21.861.
10
Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.巴雷特食管中食管腺癌的筛查、预后及治疗的变化
Curr Opin Gastroenterol. 2009 Jul;25(4):358-65. doi: 10.1097/MOG.0b013e32832c148f.

引用本文的文献

1
Chemoprevention of Barrett's Esophagus: a Systematic Review and Comprehensive Assessment of Bias.巴雷特食管的化学预防：系统评价与偏倚综合评估
Dis Esophagus. 2025 Jul 3;38(4). doi: 10.1093/dote/doaf062.
2
Surveillance of Barrett's Esophagus Patients in an Expert Center is Associated With Low Disease-Specific Mortality.在一个专家中心对巴雷特食管患者进行监测与较低的疾病特异性死亡率相关。
United European Gastroenterol J. 2025 Mar;13(2):220-228. doi: 10.1002/ueg2.12759. Epub 2025 Feb 13.
3
Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.巴雷特食管患者中基于风险分层的表观遗传生物标志物检测的时空研究
Am J Gastroenterol. 2025 Feb 12;120(6):1285-1295. doi: 10.14309/ajg.0000000000003367.
4
Identification of as a Potential Biomarker for Progression from Barrett's Esophagus to Esophageal Adenocarcinoma: A Comprehensive Bioinformatic Analysis.鉴定[具体内容]作为从巴雷特食管进展为食管腺癌的潜在生物标志物：一项全面的生物信息学分析。 （注：原文中“Identification of as a Potential Biomarker...”这里“Identification of”后面缺少具体所鉴定的内容）
Diagnostics (Basel). 2024 Dec 19;14(24):2863. doi: 10.3390/diagnostics14242863.
5
Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett's esophagus.食管腺癌及其潜在的巴雷特食管中独特的微生物群失调和表观遗传异常。
Clin Epigenetics. 2024 Dec 19;16(1):184. doi: 10.1186/s13148-024-01801-z.
6
Microbiome of esophageal endoscopic wash samples is associated with resident flora in the esophagus and incidence of cancer.食管内镜冲洗样本的微生物组与食管常驻菌群和癌症发病率有关。
Sci Rep. 2024 Aug 22;14(1):19525. doi: 10.1038/s41598-024-67410-1.
7
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.胃食管反流病患者发展为 Barrett 食管的长期风险因素：一项纵向队列研究。
BMJ Open Gastroenterol. 2024 Mar 22;11(1):e001307. doi: 10.1136/bmjgast-2023-001307.
8
Application of Manuka honey in treatment patients with GERD.麦卢卡蜂蜜在治疗胃食管反流病患者中的应用。
Food Sci Nutr. 2023 Oct 12;12(1):172-179. doi: 10.1002/fsn3.3748. eCollection 2024 Jan.
9
Durability of radiofrequency ablation for long-segment and ultralong-segment Barrett's esophagus over 10 years.射频消融治疗长段和超长段巴雷特食管10年以上的持久性
Surg Endosc. 2024 Mar;38(3):1239-1248. doi: 10.1007/s00464-023-10608-7. Epub 2023 Dec 13.
10
Endoscopic Management of Dysplastic Barrett's Oesophagus and Early Oesophageal Adenocarcinoma.发育异常的巴雷特食管和早期食管腺癌的内镜治疗
Cancers (Basel). 2023 Sep 28;15(19):4776. doi: 10.3390/cancers15194776.

本文引用的文献

1
Endoscopic eradication of Barrett's esophagus.内镜下根除巴雷特食管。
Gastrointest Endosc. 2010 Jan;71(1):147-66. doi: 10.1016/j.gie.2009.07.026. Epub 2009 Oct 30.
2
Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.射频消融联合内镜切除治疗 Barrett 食管伴早期肿瘤的疗效。
Clin Gastroenterol Hepatol. 2010 Jan;8(1):23-9. doi: 10.1016/j.cgh.2009.07.003. Epub 2009 Aug 11.
3
An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.一项针对高危患者巴雷特食管高级别异型增生和早期食管癌的冷冻喷雾消融开放标签前瞻性试验。
Gastrointest Endosc. 2009 Oct;70(4):635-44. doi: 10.1016/j.gie.2009.02.006. Epub 2009 Jun 25.
4
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.巴雷特食管黏膜（T1a）期食管腺癌的内镜及手术治疗
Gastroenterology. 2009 Sep;137(3):815-23. doi: 10.1053/j.gastro.2009.05.059. Epub 2009 Jun 12.
5
Medication usage and the risk of neoplasia in patients with Barrett's esophagus.药物使用与巴雷特食管患者肿瘤风险。
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304. doi: 10.1016/j.cgh.2009.06.001. Epub 2009 Jun 10.
6
Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.既往诊断、内镜检查情况及食管腺癌的转归：一项基于人群的时间趋势研究
Am J Gastroenterol. 2009 Jun;104(6):1356-62. doi: 10.1038/ajg.2009.159. Epub 2009 May 12.
7
Radiofrequency ablation in Barrett's esophagus with dysplasia.巴雷特食管伴发育异常的射频消融术。
N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145.
8
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.一项关于巴雷特食管进展预测的甲基化生物标志物的多中心、双盲验证研究。
Cancer Res. 2009 May 15;69(10):4112-5. doi: 10.1158/0008-5472.CAN-09-0028. Epub 2009 May 12.
9
Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance.南欧巴雷特食管诊断趋势：对监测的影响。
Dis Esophagus. 2009;22(3):239-48. doi: 10.1111/j.1442-2050.2008.00908.x.
10
Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus.食管化生无杯状细胞柱状上皮中的肠分化。
Am J Surg Pathol. 2009 Jul;33(7):1006-15. doi: 10.1097/PAS.0b013e31819f57e9.